Nutrition 21, Inc., a nutritional bioscience company, engages in the research, development, and commercialization of chromium-based nutrition products in the United States. Its primary product Chromax chromium picolinate is marketed to vitamin and supplement manufacturers for use in human and animal nutrition products. The company also developed Diachrom, a proprietary nutrition product, for type-2 diabetes. Its products are used in improving the structure or function of the body, and in the prevention and treatment of metabolic diseases stemming from insulin resistance, such as obesity, pre-diabetes, diabetes, depression, and cardiovascular disease. The company sells its products to the...